Android app Apple app link

Opko Health Inc.'s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals

By Yahoo! Finance   |   1 month ago
Opko Health Inc.'s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals

Opko Health Inc. (NASDAQ:OPK) shows potential with a recent collaboration agreement with Regeneron Pharmaceuticals Inc. through its subsidiary ModeX Therapeutics. The deal includes an upfront payment of $7 million and potential milestone payments exceeding $200 million per selected molecule.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.